Migrén: vizsgálatok itt: Dél-Korea
1 of 2 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peoplePost-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
- Where
- Ansan-si, Busan, Changwon-si, Daegu, Daejeon, Gangwon-do, Goyang, Goyang-si, Gwangju, Hwaseong, Hwaseong-si, Iksan, Incheon, Jeonju, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Yongin-si
- Életkor
- 19 év and over
- People
- 3000
- Run by
- AbbVie
See details and how to joinNCT06603558